ANI Pharmaceuticals | ANIP - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
AbbVie USD 645M 69M 2026-03
ANI Pharmaceuticals USD 3.64M 775K 2026-06
Aurora Cannabis CAD 230K 1.88M 2026-03
Canopy Growth CAD 12.31M 4.97M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Heron Therapeutics USD 600K 100K 2024-12
Hikma Pharmaceutical USD 67M 47M 2025-12
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Novartis USD 281M 8M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Perrigo USD 7.61B 373.8M 2026-06
Sun Pharmaceuticals INR 859M 139.6M 2026-03
Teva Pharmaceutical Industries USD 195M 21M 2026-06